Selected research
Industry Research
Saliva Substitute Industry Research Report 2026
Market perspective
The global Saliva Substitute market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Saliva Substitute is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Saliva Substitute is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Saliva Substitute is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Saliva Substitute include Biotene, Xlear, Oasis, Glandosane, TheraBreath, OraCoat, Lubricity Labs, SalivaMAX（Forward Science） and Dentiva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Saliva Substitute market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Saliva Substitute Market by Company
Biotene
Xlear
Oasis
Glandosane
TheraBreath
OraCoat
Lubricity Labs
SalivaMAX（Forward Science）
Dentiva
GC Dry Mouth Products
Colgate
Hager Pharma
SmartMouth
Saliva Substitute Segment by Type
Spray
Gel
Lozenge
Other
Saliva Substitute Segment by Application
Supermarket
Specialty Store
Online Sales
Other
Saliva Substitute Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saliva Substitute market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Saliva Substitute and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saliva Substitute.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Saliva Substitute manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Saliva Substitute by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Saliva Substitute in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Spray
- Gel
- Lozenge
- Other
Applications
- Supermarket
- Specialty Store
- Online Sales
- Other
Companies covered
- Biotene
- Xlear
- Oasis
- Glandosane
- TheraBreath
- OraCoat
- Lubricity Labs
- SalivaMAX（Forward Science）
- Dentiva
- GC Dry Mouth Products
- Colgate
- Hager Pharma
- SmartMouth
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Saliva Substitute Market Size (2021-2032)
- 2.2.2 Global Saliva Substitute Sales (2021-2032)
- 2.2.3 Global Saliva Substitute Market Average Price (2021-2032)
- 2.3 Saliva Substitute by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Spray
- 2.3.3 Gel
- 2.3.4 Lozenge
- 2.3.5 Other
- 2.4 Saliva Substitute by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Supermarket
- 2.4.3 Specialty Store
- 2.4.4 Online Sales
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Saliva Substitute Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Saliva Substitute Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Saliva Substitute Revenue of Manufacturers (2021-2026)
- 3.4 Global Saliva Substitute Average Price by Manufacturers (2021-2026)
- 3.5 Global Saliva Substitute Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Saliva Substitute, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Saliva Substitute, Product Type & Application
- 3.8 Global Manufacturers of Saliva Substitute, Established Date
- 3.9 Global Saliva Substitute Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Biotene
- 4.1.1 Biotene Company Information
- 4.1.2 Biotene Business Overview
- 4.1.3 Biotene Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Biotene Saliva Substitute Product Portfolio
- 4.1.5 Biotene Recent Developments
- 4.2 Xlear
- 4.2.1 Xlear Company Information
- 4.2.2 Xlear Business Overview
- 4.2.3 Xlear Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Xlear Saliva Substitute Product Portfolio
- 4.2.5 Xlear Recent Developments
- 4.3 Oasis
- 4.3.1 Oasis Company Information
- 4.3.2 Oasis Business Overview
- 4.3.3 Oasis Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Oasis Saliva Substitute Product Portfolio
- 4.3.5 Oasis Recent Developments
- 4.4 Glandosane
- 4.4.1 Glandosane Company Information
- 4.4.2 Glandosane Business Overview
- 4.4.3 Glandosane Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Glandosane Saliva Substitute Product Portfolio
- 4.4.5 Glandosane Recent Developments
- 4.5 TheraBreath
- 4.5.1 TheraBreath Company Information
- 4.5.2 TheraBreath Business Overview
- 4.5.3 TheraBreath Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TheraBreath Saliva Substitute Product Portfolio
- 4.5.5 TheraBreath Recent Developments
- 4.6 OraCoat
- 4.6.1 OraCoat Company Information
- 4.6.2 OraCoat Business Overview
- 4.6.3 OraCoat Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 OraCoat Saliva Substitute Product Portfolio
- 4.6.5 OraCoat Recent Developments
- 4.7 Lubricity Labs
- 4.7.1 Lubricity Labs Company Information
- 4.7.2 Lubricity Labs Business Overview
- 4.7.3 Lubricity Labs Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lubricity Labs Saliva Substitute Product Portfolio
- 4.7.5 Lubricity Labs Recent Developments
- 4.8 SalivaMAX（Forward Science）
- 4.8.1 SalivaMAX（Forward Science） Company Information
- 4.8.2 SalivaMAX（Forward Science） Business Overview
- 4.8.3 SalivaMAX（Forward Science） Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SalivaMAX（Forward Science） Saliva Substitute Product Portfolio
- 4.8.5 SalivaMAX（Forward Science） Recent Developments
- 4.9 Dentiva
- 4.9.1 Dentiva Company Information
- 4.9.2 Dentiva Business Overview
- 4.9.3 Dentiva Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dentiva Saliva Substitute Product Portfolio
- 4.9.5 Dentiva Recent Developments
- 4.10 GC Dry Mouth Products
- 4.10.1 GC Dry Mouth Products Company Information
- 4.10.2 GC Dry Mouth Products Business Overview
- 4.10.3 GC Dry Mouth Products Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GC Dry Mouth Products Saliva Substitute Product Portfolio
- 4.10.5 GC Dry Mouth Products Recent Developments
- 4.11 Colgate
- 4.11.1 Colgate Company Information
- 4.11.2 Colgate Business Overview
- 4.11.3 Colgate Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Colgate Saliva Substitute Product Portfolio
- 4.11.5 Colgate Recent Developments
- 4.12 Hager Pharma
- 4.12.1 Hager Pharma Company Information
- 4.12.2 Hager Pharma Business Overview
- 4.12.3 Hager Pharma Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hager Pharma Saliva Substitute Product Portfolio
- 4.12.5 Hager Pharma Recent Developments
- 4.13 SmartMouth
- 4.13.1 SmartMouth Company Information
- 4.13.2 SmartMouth Business Overview
- 4.13.3 SmartMouth Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 SmartMouth Saliva Substitute Product Portfolio
- 4.13.5 SmartMouth Recent Developments
5 Global Saliva Substitute Market Scenario by Region
- 5.1 Global Saliva Substitute Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Saliva Substitute Sales by Region: 2021-2032
- 5.2.1 Global Saliva Substitute Sales by Region: 2021-2026
- 5.2.2 Global Saliva Substitute Sales by Region: 2027-2032
- 5.3 Global Saliva Substitute Revenue by Region: 2021-2032
- 5.3.1 Global Saliva Substitute Revenue by Region: 2021-2026
- 5.3.2 Global Saliva Substitute Revenue by Region: 2027-2032
- 5.4 North America Saliva Substitute Market Facts & Figures by Country
- 5.4.1 North America Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Saliva Substitute Sales by Country (2021-2032)
- 5.4.3 North America Saliva Substitute Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Saliva Substitute Market Facts & Figures by Country
- 5.5.1 Europe Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Saliva Substitute Sales by Country (2021-2032)
- 5.5.3 Europe Saliva Substitute Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Saliva Substitute Market Facts & Figures by Country
- 5.6.1 Asia Pacific Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Saliva Substitute Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Saliva Substitute Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Saliva Substitute Market Facts & Figures by Country
- 5.7.1 South America Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Saliva Substitute Sales by Country (2021-2032)
- 5.7.3 South America Saliva Substitute Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Saliva Substitute Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Saliva Substitute Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Saliva Substitute Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Saliva Substitute Sales by Type (2021-2032)
- 6.1.1 Global Saliva Substitute Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Saliva Substitute Sales Market Share by Type (2021-2032)
- 6.2 Global Saliva Substitute Revenue by Type (2021-2032)
- 6.2.1 Global Saliva Substitute Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Saliva Substitute Revenue Market Share by Type (2021-2032)
- 6.3 Global Saliva Substitute Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Saliva Substitute Sales by Application (2021-2032)
- 7.1.1 Global Saliva Substitute Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Saliva Substitute Sales Market Share by Application (2021-2032)
- 7.2 Global Saliva Substitute Revenue by Application (2021-2032)
- 7.2.1 Global Saliva Substitute Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Saliva Substitute Revenue Market Share by Application (2021-2032)
- 7.3 Global Saliva Substitute Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Saliva Substitute Value Chain Analysis
- 8.1.1 Saliva Substitute Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Saliva Substitute Production Mode & Process
- 8.2 Saliva Substitute Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Saliva Substitute Distributors
- 8.2.3 Saliva Substitute Customers
9 Global Saliva Substitute Analyzing Market Dynamics
- 9.1 Saliva Substitute Industry Trends
- 9.2 Saliva Substitute Industry Drivers
- 9.3 Saliva Substitute Industry Opportunities and Challenges
- 9.4 Saliva Substitute Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst